TITLE

Prevalencia y comorbilidad de dislipidemias en el primer nivel de atención

AUTHOR(S)
Martínez-Hernández, Antonio Francisco; Chávez-Aguirre, Rocío
PUB. DATE
September 2007
SOURCE
Revista Medica del IMSS;sep/oct2007, Vol. 45 Issue 5, p469
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To evaluate the prevalence of dyslipidemia and comorbidity in adults older than 20 years attending to the family medicine clinic # 20 of Instituto Mexicano del Seguro Social and to compare it with the prevalence in México. Method: the study was conducted in 2005 by using a cross-sectional design; dyslipidemia was ascertained by measuring total cholesterol and triglycerides. Additional variables were: gender, age, health status, and diagnosis of diabetes, hypertension, overweight, and obesity. A standardization procedure and a dry run were carried out before beginning the data collection phase. Results: The study included 165 participants, 35.2 % had hypercholesterolemia and 63.6 % had hypertriglyceridemia. According to the variables, 20.0% of people aged 40 to 59 years of age; 57.1% of women; 40.9% of overweight, 40.9% of obese and 49.5% of healthy patients had hypertriglyceridemia; while 68.9% of women; 44.8% of patients with hypertension, and 51.7 % of overweight patients had hypercholesterolemia. Conclusion: The prevalence of hypertriglyceridemia and hypercholesterolemia were significantly different from previous reports (hypercholesterolemia z < 2.83; p < 0.001; hypertriglyceridemia z = 7.83; p < 00.1), being higher in women and increasing with aging.
ACCESSION #
28122238

 

Related Articles

  • Dyslipidemia.  // Encyclopedic Reference of Molecular Pharmacology;2004, p328 

    This article presents an encyclopedia entry for dyslipidemia. It refers to the change in the normal blood lipid concentrations. In particular, hypercholesterolemia is a major cause of increased atherogenic risk, leading to heart diseases, cerebrovascular diseases and peripheral vascular...

  • Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia. Marinangeli, Christopher P. F.; Jones, Peter J. H. // Nutrition & Metabolism;2010, Vol. 7, p76 

    As hyperlipidemia, including hypercholesterolemia (HC) and hypertriglyceridemia (HTN), continue to challenge North America's healthcare systems, patients continue to seek efficacious and safe natural therapies that complement pharmaceutical interventions. However, despite the ever-growing body...

  • cholesteremia, cholesterolemia.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p439 

    An encyclopedia entry for "cholesteremia" or "cholesterolemia" is presented.

  • Plasma High-Density Lipoproteins and Ischemic Heart Disease. Streja, Dan; Steiner, George; Kwiterovich, Peter O. // Annals of Internal Medicine;Dec78, Vol. 89 Issue 6, p871 

    Investigates the signs of familial hypercholesterolemia in a Newfoundland kindred. Description of primary hyperbetalipoproteinemia; Interrelationships of plasma high-density lipoprotein cholesterol levels and other plasma lipids and lipoproteins and the presence of ischemic heart disease;...

  • Statins leading the charge against high cholesterol. Fleming Jr., Harris // Drug Topics;10/5/98, Vol. 142 Issue 19, p34 

    States that there is a dramatic increase in the number of patients treated for hyperlipidemia and hypercholesterolemia in the United States, according to the report `Market View '98: Cholesterol Reduction Market.' In-depth look at the cholesterol diseases; Details on the drug therapies used to...

  • Managing Hyperlipidaemia in the Elderly: Special Considerations for a Population at High Risk. Aronow, Wilbert S. // Drugs & Aging;2006, Vol. 23 Issue 3, p181 

    Numerous randomised, double-blind, placebo-controlled studies and observational studies have shown that HMG-CoA reductase inhibitors (statins) reduce mortality and major cardiovascular events in elderly high-risk persons with hypercholesterolaemia. The Heart Protection Study showed that statins...

  • Diagnosis and Management of Lipoprotein Abnormalities. Batiste, Marcelo C.; Schaefer, Ernst J. // Nutrition in Clinical Care;May/Jun2002, Vol. 5 Issue 3, p115 

    Abstract Abnormal lipid and lipoprotein cholesterol values have been defined as a low-density lipoprotein (LDL) cholesterol (C) value of 160 mg/dL (4.1 mmol/L) or greater, a high-density lipoprotein (HDL) C value less than 40 mg/dL (1.0 mmol/L), triglycerides (TG) 150 mg/dL (1.7 mmol/L) or...

  • Effects of Combined Treatment with Simvastatin and L-Carnitine on Triglyceride Levels in Diabetic Patients with Hyperlipidaemia. Brescia, F.; Balestra, E.; Iasella, M.G.; Damato, A.B. // Clinical Drug Investigation;2002 Supplement 1, Vol. 22 Issue 1, p23 

    Objective: To investigate the effects of L-carnitine, coadministered with simvastatin, on hypercholesterolaemia and hypertriglyceridaemia in patients with diabetes. Design: Randomised, open, parallel-group study. Setting: One investigational centre (hospital). Patients: Thirty-two patients with...

  • Hypercholesterolemia in a Health Care Worker Receiving Thyroxine after Postexposure Prophylaxis for Human Immunodeficiency Virus Infection. Nerad, Judith L.; Kessler, Harold A. // Clinical Infectious Diseases;6/1/2001, Vol. 32 Issue 11, p1635 

    Focuses on a case of hypercholesterolemia that occurred after the start of highly active antiretroviral therapy following a needlestick exposure to HIV virus in an HIV-negative health care worker who was receiving thyroid replacement therapy. Case report; Discussion.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics